In another paper by Kakavand H. et al. [15], the authors tried to understand whether PD-L1 expression in MM cells present in the sentinel lymph node of positive patients could have any impact on their management and potential use of PD-1/PD-L1 inhibitors in the adjuvant setting. The gene discussed is CD274; the disease is Miyoshi myopathy.